Acorai

Acorai develops a non-invasive intracardiac pressure monitoring device to improve heart failure management. Its monitoring system, designated a breakthrough device by the FDA, utilizes a patented sensor system and machine learning. The company aims to become the new standard in heart failure management and a leader in non-invasive patient care.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $4.5M

Date: 22-Jan-2024

Investors: Solardis Health Ventures, KHP Ventures, Carma Fund, other US investors, existing investors from across Sweden and the EU

Markets: Medtech, Healthcare

HQ: Helsingborg, Skåne, Sweden

Founded: 2019

Website: https://acorai.com/

LinkedIn: https://www.linkedin.com/company/acorai

Twitter: https://twitter.com/Acorai_Official

Instagram: